Virtus Investment Advisers, Inc. Immunocore Holdings PLC Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 12,472 shares of IMCR stock, worth $397,482. This represents 0.14% of its overall portfolio holdings.
Number of Shares
12,472
Previous 11,847
5.28%
Holding current value
$397,482
Previous $351,000
11.4%
% of portfolio
0.14%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding IMCR
# of Institutions
134Shares Held
45.6MCall Options Held
269KPut Options Held
174K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$225 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$195 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$155 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$120 Million0.1% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$74 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.4B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...